SCHEMBL17889592

SCHEMBL17889592

COc1ccc(-c2sc(NC(=O)C3CCCC3)nc2C)cc1S(=O)(=O)Nc1c(C)ccnc1C

nearest known ligand 0.75

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 16/20 0.75
PIK3C2G O75747 3/20 0.75
PIK3CD O00329 3/20 0.75
PIK3CG P48736 3/20 0.75
PIK3CA P42336 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17904349 0.91 PI4KB (0.62) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851828 0.90 PI4KB (0.75) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851717 0.89 PI4KB (0.82) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851673 0.89 PIK3C2G (0.81) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851672 0.89 PI4KB (0.76) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851927 0.88 PI4KB (0.77) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851900 0.88 PIK3CD (0.74) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851913 0.87 PI4KB (0.88) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851894 0.87 PIK3C2G (0.84) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA
SCHEMBL14851912 0.87 PI4KB (0.74) PI4KBPIK3C2GPIK3CDPIK3CGPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3419980-B1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY UNIV LELAND STANFORD JUNIOR (US) 2025-01-01 EP disclosed
US-20220017507-A1 PI-Kinase Inhibitors with Anti-Infective Activity THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-01-20 US disclosed
US-11091472-B2 PI-kinase inhibitors with anti-infective activity THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-17 US disclosed
WO-2020146657-A1 PI4-KINASE INHIBITORS WITH ANTI-CANCER ACTIVITY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2020-07-16 WO disclosed
US-10428060-B2 PI-kinase inhibitors with anti-infective activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2019-10-01 US disclosed
US-10428060-B2 PI-kinase inhibitors with anti-infective activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2019-10-01 US disclosed
US-20180170924-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2018-06-21 US disclosed
US-20180170924-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2018-06-21 US disclosed
US-9926309-B2 Pi-kinase inhibitors with anti-infective activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-03-27 US disclosed
US-9926309-B2 Pi-kinase inhibitors with anti-infective activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-03-27 US disclosed
WO-2017147526-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2017-08-31 WO disclosed
US-20160194314-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-07-07 US disclosed
US-20160194314-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11091472-B2 PI-kinase inhibitors with anti-infective activity PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3C2G 100/4885PIK3CD 20/4885
US-20220017507-A1 PI-Kinase Inhibitors with Anti-Infective Activity PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3C2G 98/4885PIK3CD 23/4885
US-20180170924-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3C2G 100/4885PIK3CD 20/4885
US-20160194314-A1 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3C2G 100/4885PIK3CD 20/4885
US-10428060-B2 PI-kinase inhibitors with anti-infective activity PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3C2G 100/4885PIK3CD 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.